CANA Financials 07/16/2014 01:05:02 Cannabis-Rx I
Post# of 6
Cannabis-Rx Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 166 109 4
Non-Recurring Items - - -
Other - - -
Operating Income (166) (109) (4)
Income From Continuing Operations
Add'l Income/Expense Items - - -
Earnings Before Interest and Tax (166) (109) (4)
Interest Expense 89 - -
Earnings Before Tax (256) (109) (4)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (256) (109) (4)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (256) (109) (4)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (256) (109) (4)